Clinical Trials Logo

Clinical Trial Summary

The most common reason for applying to a hospital in the postoperative period due to the double J stent inserted during operations of the uteroscopic lithotripsy is reflected pain (T11-L2). The posterior approximation QL block (QL-P) is known to extend more easily to the thoracic paravertebral cavity or thoracolumbar plane, creating analgesia from T 7' to L 1'. The effects of double J catheter in patients are followed by 'Ureteral Stent Symptom Scoring Survey'. QL-P for postoperative analgesia after URS operations Our primary hypothesis in this prospective, randomized, controlled study is that the symptoms of the sub-urinary system associated with the DJS of the QL-P block will decrease. Our secondary hypotheses in the study are to investigate the effects of the unilateral QL-P block, made under ultrasound guidance, on pain scores that occur after ureteroscopic lithotripsy operations due to unilateral ureteral stones made under spinal anesthesia.


Clinical Trial Description

All patients will be placed in a seated position to apply spinal anesthesia. Patients will be entered into the interspinal distance from the Lumbar(L) 3-L4 spinal interval or the L4-L5 spinal interval with a needle of 25 Gauge Quincke, creating a sensory block at level 0.5% hyperbaric bupivacaine with Trocal(T) 10. After the T 10 level sensory block is formed, patients will be divided into 2 groups. 1. Patients in the group are the control group and will be placed in the lithotomy position for the surgical procedure after the sensory block. 2. In the patients in the group, lateral decubitus position will be given to make quadratus lumborum block. After the skin is prepared sterile, the convex ultrasound probe (SonoSiteMTurbo; FUJIFILM SonoSite, Bothell, WA) will be inserted perpendicular to the spine in the 12th vertebral body and then forwarded to the lateral to view the quaratuslumborum muscle and psoas muscle. In-plane method with the lateral of the probe 22 gauge needle, between the quadratus lumborum muscle and the front layer of the thoracolumbar fascia after the position accuracy is determined with 1-2 mL serum physiolgic, %0.375 Mg of bupivacaine will be injected in 20 ml. The patient will then be placed in the lithotomy position for the surgical procedure. Patients of a blind research assistant to the group distribution are seen on-site in the 1st, 6th, 12th and 24th hours after surgery, postoperative 7. by calling by phone per day, pain intensities will be assessed by 'numerical assessment scale' (Numeric Rating Scala: NRS). For half an hour, 5 mg of tramadol will be added if NRS is above 100 mg. For 48 hours, tramadol, non-steroidal anti-inflammatory consumption will be monitored. In addition, complications such as local anesthesia toxicity, allergy, internal organ injury, postoperative nausea and vomiting, postoperative bleeding will be recorded. In addition, on the 7th post-operative day, the pain level of the patients will be evaluated with NRS and the sub-productive system septomas connected to DJS are evaluated with the ureteralstent symptom scoring questionnaire (while inserted in the stent). In our clinic, approximately 1 month after URS operations, control cystoscopy is performed and ureteral stents are removed. After 5 days of removal of the ureteral stent, the symptoms of the lower urinary system will be questioned with the ureteral stent symptom scoring questionnaire (after the stent is removed). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06290323
Study type Interventional
Source Mugla Sitki Koçman University
Contact
Status Active, not recruiting
Phase N/A
Start date January 25, 2024
Completion date May 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT04856748 - Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
Completed NCT03623880 - Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders N/A
Enrolling by invitation NCT06317116 - Examining the Relationship Between Core Muscles and Bladder Issues in Children
Completed NCT03625843 - Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing N/A
Recruiting NCT05814614 - Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical Stimulation N/A
Recruiting NCT04288427 - 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy N/A
Completed NCT03339609 - Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children N/A
Completed NCT02330107 - Auriculotherapy on Lower Urinary Tract Symptoms in Elderly Men N/A
Terminated NCT02003742 - Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH Phase 3
Terminated NCT01003249 - Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen Phase 4
Completed NCT01078545 - Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) N/A
Completed NCT02074644 - Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia N/A
Recruiting NCT03802851 - HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer N/A
Active, not recruiting NCT05415748 - Deprescribing Tamsulosin in Older Men Phase 4
Recruiting NCT05702294 - Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries . N/A
Enrolling by invitation NCT05537272 - The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy Phase 4
Recruiting NCT05826691 - Benign Prostate Surgery and QOL and Sexual Function
Completed NCT04104100 - Prevalence and Risk Factor of NP in Women With LUTS
Completed NCT04190641 - Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder N/A
Recruiting NCT06012903 - Lower Urinary Tract Symptoms and School Functioning in Children